Home › Funds › Trails Edge Capital Partners, LP › IVA
Trails Edge Capital Partners, LP position in IVA
INVENTIVA SA · Health Care
Trails Edge Capital Partners, LP reported holding 2,657,997 shares of IVA (INVENTIVA SA) in its Q2 2026 13F filing — a position valued at US$10.0M, representing 1.60% of its reported portfolio and ranking #26 among its reported holdings. Trails Edge Capital Partners, LP has disclosed IVA holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Trails Edge Capital Partners, LP's IVA position evolved
Trails Edge Capital Partners, LP first disclosed a stake in IVA in Q4 2025 at 2,657,997 shares (US$12.4M). The position peaked in Q1 2026 at 2,657,997 shares, worth US$14.8M. Across 3 filings, Trails Edge Capital Partners, LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 2,657,997 shares valued at US$10.0M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 2.66M | $12.36M | New |
| Q1 2026 | 2.66M | $14.75M | Hold |
| Q2 2026 | 2.66M | $10.05M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IVA and 13F data
IVA (INVENTIVA SA) is a Health Care company. 94 other funds we track also report a position in IVA — the largest reported positions include Caligan Partners LP (US$30.9M), Samsara BioCapital, LLC (US$23.9M), Paradigm Biocapital Advisors LP (US$15.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IVA
- Caligan Partners LP 8.16M sh · $30.86M · Q2 2026
- Samsara BioCapital, LLC 6.31M sh · $23.87M · Q2 2026
- Paradigm Biocapital Advisors LP 4.00M sh · $15.12M · Q2 2026
- ADAR1 Capital Management, LLC 3.61M sh · $13.63M · Q2 2026
- Andera Partners 3.63M sh · $13.41M · Q3 2026
- SymBiosis Capital Partners, LLC 2.35M sh · $13.06M · Q1 2026
- Squadron Capital Management LLC 2.44M sh · $9.20M · Q2 2026
- Patient Square Capital LP 1.97M sh · $7.44M · Q2 2026
- NEXTBio Capital Management LP 1.79M sh · $6.76M · Q2 2026
- Yu Fan 1.50M sh · $5.67M · Q2 2026
- NEA Management Company, LLC 1.46M sh · $5.53M · Q2 2026
- STEMPOINT CAPITAL LP 1.43M sh · $5.39M · Q2 2026
More on Trails Edge Capital Partners, LP
FAQ
How long has Trails Edge Capital Partners, LP held IVA?
Trails Edge Capital Partners, LP has disclosed IVA holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Trails Edge Capital Partners, LP's current position in IVA?
As of Q2 2026, Trails Edge Capital Partners, LP holds 2.66M shares of IVA (INVENTIVA SA), valued at $10.05M, representing 1.60% of its reported portfolio and ranking #26.
Has Trails Edge Capital Partners, LP been buying or selling IVA?
In the latest 13F filing (Q2 2026), Trails Edge Capital Partners, LP held unchanged its position in IVA. The position peaked in Q1 2026 at 2.66M shares.
Which other funds hold IVA?
Other major institutional holders of IVA include Caligan Partners LP, Samsara BioCapital, LLC, Paradigm Biocapital Advisors LP, among 94 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.